CBS 2019
CBSMD教育中心
English

动脉粥样硬化性心血管疾病

科研文章

荐读文献

Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA) Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials Comprehensive Investigation of Circulating Biomarkers and their Causal Role in Atherosclerosis-related Risk Factors and Clinical Events When, where, and how to target vascular inflammation in the post-CANTOS era? 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic? Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of Cardiology

Original Research2019 Feb 12;139(7):965-980.

JOURNAL:Circulation. Article Link

Circadian-Regulated Cell Death in Cardiovascular Diseases

Rabinovich-Nikitin I, Lieberman B, Martino TA et al. Keywords: biology; cardiovascular diseases; circadian rhythm; ischemia; science; translational medical research

FULL TEXT PDF